Integrated DNA Technologies Launches First Cas9 Enzyme That Drastically Reduces CRISPR Off-Target Effects Without Significant Loss Of On-Target Activity Post author:Sam Post published:July 31, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Stoke Therapeutics Comes Out of Seed Mode With $40M and Ex-Sarepta CEO at Its Helm January 3, 2018 FDA Grants Orphan Drug Designation To Prometic's PBI-4050 Drug For The Treatment Of Alstr??m Syndrome March 2, 2017 Bausch & Lomb Introduces Renu Advanced Formula Multi-Purpose Solution May 21, 2017
FDA Grants Orphan Drug Designation To Prometic's PBI-4050 Drug For The Treatment Of Alstr??m Syndrome March 2, 2017